Header Logo

Connection

BRADY MOFFETT to Infant, Newborn

Back to Details
This is a "connection" page, showing publications BRADY MOFFETT has written about Infant, Newborn.
BRADY MOFFETT
Connection Strength
1.709
Infant, Newborn
  1. Antibiotic Utilization and Efficacy Associated With Treating Pediatric Urinary Tract Infections in Texas Medicaid Patients in the First Year of Life. Pediatr Infect Dis J. 2021 11 01; 40(11):993-996.
    View in: PubMed
    Score: 0.077
  2. Population Pharmacokinetics of Vancomycin in Pediatric Extracorporeal Membrane Oxygenation. Pediatr Crit Care Med. 2018 10; 19(10):973-980.
    View in: PubMed
    Score: 0.063
  3. Fosphenytoin Population Pharmacokinetics in the Acutely Ill Pediatric Population. Pediatr Crit Care Med. 2018 08; 19(8):748-754.
    View in: PubMed
    Score: 0.062
  4. Phenobarbital population pharmacokinetics across the pediatric age spectrum. Epilepsia. 2018 07; 59(7):1327-1333.
    View in: PubMed
    Score: 0.061
  5. Increased Fracture Risk with Furosemide Use in Children with Congenital Heart Disease. J Pediatr. 2018 08; 199:92-98.e10.
    View in: PubMed
    Score: 0.061
  6. Enoxaparin Population Pharmacokinetics in the First Year of Life. Ther Drug Monit. 2017 12; 39(6):632-639.
    View in: PubMed
    Score: 0.059
  7. Population pharmacokinetics of human antithrombin concentrate in paediatric patients. Br J Clin Pharmacol. 2017 Nov; 83(11):2450-2457.
    View in: PubMed
    Score: 0.058
  8. Spironolactone effect on potassium supplementation in paediatric cardiac intensive care patients. J Clin Pharm Ther. 2017 Aug; 42(4):433-437.
    View in: PubMed
    Score: 0.056
  9. Efficacy of sequential nephron blockade with intravenous chlorothiazide to promote diuresis in cardiac intensive care infants. Cardiol Young. 2017 Aug; 27(6):1104-1109.
    View in: PubMed
    Score: 0.055
  10. Prostaglandin Availability and Association with Outcomes for Infants with Congenital Heart Disease. Pediatr Cardiol. 2016 Feb; 37(2):338-44.
    View in: PubMed
    Score: 0.051
  11. Efficacy of digoxin in comparison with propranolol for treatment of infant supraventricular tachycardia: analysis of a large, national database. Cardiol Young. 2015 Aug; 25(6):1080-5.
    View in: PubMed
    Score: 0.047
  12. Trends in parenteral direct thrombin inhibitor use in pediatric patients: analysis of a large administrative database. Arch Pathol Lab Med. 2014 Sep; 138(9):1229-32.
    View in: PubMed
    Score: 0.047
  13. Flecainide use in children with cardiomyopathy or structural heart disease. Pediatr Cardiol. 2015 Jan; 36(1):146-50.
    View in: PubMed
    Score: 0.047
  14. Vancomycin-associated acute kidney injury in pediatric cardiac intensive care patients. Congenit Heart Dis. 2015 Jan-Feb; 10(1):E6-10.
    View in: PubMed
    Score: 0.046
  15. National prescribing trends for heart failure medications in children. Congenit Heart Dis. 2015 Jan-Feb; 10(1):78-85.
    View in: PubMed
    Score: 0.046
  16. Anticoagulation therapy trends in children supported by ventricular assist devices: a multi-institutional study. ASAIO J. 2014 Mar-Apr; 60(2):211-5.
    View in: PubMed
    Score: 0.045
  17. Amiodarone monitoring practices in pediatric hospitals in the United States. Pediatr Cardiol. 2013; 34(8):1762-6.
    View in: PubMed
    Score: 0.043
  18. Analysis of vancomycin therapeutic drug monitoring trends at pediatric hospitals. Pediatr Infect Dis J. 2013 Jan; 32(1):32-5.
    View in: PubMed
    Score: 0.042
  19. Response to intravenous potassium chloride supplementation in pediatric cardiac intensive care patients. Pediatr Cardiol. 2013 Apr; 34(4):887-92.
    View in: PubMed
    Score: 0.042
  20. Ketorolac-associated renal morbidity: risk factors in cardiac surgical infants. Cardiol Young. 2013 Oct; 23(5):752-4.
    View in: PubMed
    Score: 0.041
  21. Use of 4-mg/kg/24-hour empiric aminoglycoside dosing in preoperative neonates with congenital heart disease. Ann Pharmacother. 2012 Sep; 46(9):1193-7.
    View in: PubMed
    Score: 0.041
  22. Impact of pharmacotherapy on interstage outcomes in single ventricle infants. Congenit Heart Dis. 2011 Jul-Aug; 6(4):286-93.
    View in: PubMed
    Score: 0.038
  23. High-dose sotalol is safe and effective in neonates and infants with refractory supraventricular tachyarrhythmias. Pediatr Cardiol. 2011 Oct; 32(7):896-903.
    View in: PubMed
    Score: 0.037
  24. Vancomycin nephrotoxicity may be overstated. J Pediatr. 2011 May; 158(5):865-6; author reply 866.
    View in: PubMed
    Score: 0.037
  25. Acute kidney injury and increasing nephrotoxic-medication exposure in noncritically-ill children. Clin J Am Soc Nephrol. 2011 Apr; 6(4):856-63.
    View in: PubMed
    Score: 0.037
  26. Gentamicin dosing for pediatric patients with congenital heart disease. Pediatr Cardiol. 2010 Aug; 31(6):761-5.
    View in: PubMed
    Score: 0.035
  27. Sodium-nitroprusside-induced cyanide toxicity in pediatric patients. Expert Opin Drug Saf. 2009 Sep; 8(5):599-602.
    View in: PubMed
    Score: 0.033
  28. Evaluation of sodium nitroprusside toxicity in pediatric cardiac surgical patients. Ann Pharmacother. 2008 Nov; 42(11):1600-4.
    View in: PubMed
    Score: 0.031
  29. Medication dosing and renal insufficiency in a pediatric cardiac intensive care unit: impact of pharmacist consultation. Pediatr Cardiol. 2008 Jul; 29(4):744-8.
    View in: PubMed
    Score: 0.030
  30. Acetazolamide therapy for hypochloremic metabolic alkalosis in pediatric patients with heart disease. Am J Ther. 2007 Jul-Aug; 14(4):331-5.
    View in: PubMed
    Score: 0.029
  31. Therapeutic levels of intravenous procainamide in neonates: a retrospective assessment. Pharmacotherapy. 2006 Dec; 26(12):1687-93.
    View in: PubMed
    Score: 0.028
  32. Safety of ketorolac in neonates and infants after cardiac surgery. Paediatr Anaesth. 2006 Apr; 16(4):424-8.
    View in: PubMed
    Score: 0.026
  33. Nesiritide therapy in a term neonate with renal disease. Pharmacotherapy. 2006 Feb; 26(2):281-4.
    View in: PubMed
    Score: 0.026
  34. Optimizing Vancomycin Dosing and Monitoring in Neonates and Infants Using Population Pharmacokinetic Modeling. Antimicrob Agents Chemother. 2022 04 19; 66(4):e0189921.
    View in: PubMed
    Score: 0.020
  35. Understanding the Role of Pharmacometrics-Based Clinical Decision Support Systems in Pediatric Patient Management: A Case Study Using Lyv Software. J Clin Pharmacol. 2021 06; 61 Suppl 1:S125-S132.
    View in: PubMed
    Score: 0.019
  36. Extracorporeal Membrane Oxygenation Mortality in High-Risk Populations: An Analysis of the Pediatric Health Information System Database. ASAIO J. 2020 03; 66(3):327-331.
    View in: PubMed
    Score: 0.017
  37. Characteristics and outcomes of children with congenital heart disease needing diaphragm plication. Cardiol Young. 2020 Jan; 30(1):62-65.
    View in: PubMed
    Score: 0.017
  38. Characteristics and outcomes of children with ductal-dependent congenital heart disease and esophageal atresia/tracheoesophageal fistula: A multi-institutional analysis. Surgery. 2018 04; 163(4):847-853.
    View in: PubMed
    Score: 0.015
  39. Epinephrine syringe exchange events in a paediatric cardiovascular ICU: analysing the storm. Cardiol Young. 2018 Mar; 28(3):409-415.
    View in: PubMed
    Score: 0.015
  40. Antithrombin Concentrate Use in Children Receiving Unfractionated Heparin for Acute Thrombosis. J Pediatr. 2015 Sep; 167(3):645-9.
    View in: PubMed
    Score: 0.012
  41. Evaluating the Safety of Intraoperative Antiarrhythmics in Pediatric Cardiac Surgery Patients. Pediatr Cardiol. 2015 Oct; 36(7):1465-9.
    View in: PubMed
    Score: 0.012
  42. Efficacy and safety of high-dose propranolol for the management of infant supraventricular tachyarrhythmias. J Pediatr. 2015 Jan; 166(1):115-8.
    View in: PubMed
    Score: 0.012
  43. Trends in pharmacotherapy for neonatal hypotension. J Pediatr. 2014 Oct; 165(4):697-701.e1.
    View in: PubMed
    Score: 0.012
  44. Angiotensin-converting enzyme inhibitor nephrotoxicity in neonates with cardiac disease. Pediatr Cardiol. 2014 Mar; 35(3):499-506.
    View in: PubMed
    Score: 0.011
  45. Incidence and treatment of chylothorax after cardiac surgery in children: analysis of a large multi-institution database. J Thorac Cardiovasc Surg. 2014 Feb; 147(2):678-86.e1; discussion 685-6.
    View in: PubMed
    Score: 0.011
  46. Impact of postoperative nutrition on weight gain in infants with hypoplastic left heart syndrome. J Thorac Cardiovasc Surg. 2014 Apr; 147(4):1319-25.
    View in: PubMed
    Score: 0.011
  47. Impact of dexmedetomidine on early extubation in pediatric cardiac surgical patients. Intensive Care Med. 2011 Apr; 37(4):686-90.
    View in: PubMed
    Score: 0.009
  48. Captopril induced reversible acute renal failure in a premature neonate with double outlet right ventricle and congestive heart failure. World J Pediatr. 2011 Feb; 7(1):89-91.
    View in: PubMed
    Score: 0.009
  49. Viral endomyocardial infection is an independent predictor and potentially treatable risk factor for graft loss and coronary vasculopathy in pediatric cardiac transplant recipients. J Am Coll Cardiol. 2010 Aug 10; 56(7):582-92.
    View in: PubMed
    Score: 0.009
  50. Safety and efficacy of nesiritide in pediatric heart failure. J Card Fail. 2007 Sep; 13(7):541-8.
    View in: PubMed
    Score: 0.007
  51. A prospective evaluation of nesiritide in the treatment of pediatric heart failure. Pediatr Cardiol. 2006 Jul-Aug; 27(4):402-7.
    View in: PubMed
    Score: 0.007
  52. Hemodynamic effects of rescue protocol hydrocortisone in neonates with low cardiac output syndrome after cardiac surgery. Pediatr Crit Care Med. 2005 Nov; 6(6):655-9.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.